Study Reveals Foster Children 4x More Likely to Get Psychotropic Drugs Than Non-Foster Children
Study Reveals Foster Children 4x More Likely to Get Psychotropic Drugs Than Non-Foster Children
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study Reveals Foster Children 4x More Likely to Get Psychotropic Drugs Than Non-Foster Children
The FDA granted an accelerated approval for Talvey to treat patients with relapsed/refractory multiple myeloma.
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted...
Talquetamab-tgvs (Talvey) is a first-in-class bispecific antibody that binds to GPRC5D and CD3 to induce T cell-mediated killing of GPRC5D-expressing multiple myeloma cells.
– LINZESS EUTRx prescription demand growth increased 9% year-over-year; LINZESS U.S. net sales of $270 million, an increase of 9% year-over-year – – Expands clinical utility of LINZESS with...